Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$498K Buy
+2,630
New +$390K ﹤0.01% 168
2023
Q3
Sell
-3,115
Closed -$571K 304
2023
Q2
$571K Sell
3,115
-2,757
-47% -$397K 0.01% 215
2023
Q1
$782K Sell
5,872
-2,580
-31% -$303K 0.02% 181
2022
Q4
$671K Buy
8,452
+1,114
+15% +$78.5K 0.02% 174
2022
Q3
$444K Buy
+7,338
New +$474K 0.01% 185
2022
Q1
Sell
-1,944
Closed -$145K 231
2021
Q4
$145K Buy
+1,944
New +$115K ﹤0.01% 105

Other funds holding ACLS

Lee Ainslie's ACLS Position: Q2 2026 in Review

Lee Ainslie opened a new position in Axcelis (ACLS) in Q2 2026: 2,630 shares worth $498K. The stake represents ﹤0.01% of the portfolio and ranks #168 among its holdings. This is a return to the name: Lee Ainslie previously reported a position in ACLS as recently as Q2 2023.

Lee Ainslie first reported a position in ACLS in Q4 2021 and has held it in 6 quarters since. The position peaked at $782K in Q1 2023. 439 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Lee Ainslie held 2,630 shares of Axcelis worth $498K as of Q2 2026.
  • Axcelis was a new Lee Ainslie position in Q2 2026.
  • Axcelis made up ﹤0.01% of Lee Ainslie's portfolio in Q2 2026, its #168 holding.
  • Lee Ainslie first reported a position in Axcelis in Q4 2021 and has held it in 6 quarters since.
  • Lee Ainslie's Axcelis position peaked at $782K in Q1 2023.
  • 439 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Maverick Capital's 13F filing for Q2 2026, filed 14 Aug 2026.